2 minute read

2020 Financial Statements

2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting

STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE Australian and New Zealand Society of Nuclear MedicineYEAR ENDED 31ST DECEMBER 2020 Limited ABN 35 133 630 029

STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 31ST DECEMBER, 2020

Note 2020 2019 $ $

REVENUE EXPENSES

Conference, meeting and committee expenses Journal expenses Research grant Management costs Administration & ARTnet expenses Depreciation expenses Website Development and maintenance costs Write off of equipment 2(a) 284,634 359,680

(131,364) (90,832) (13,267) (11,704) (19,454) (21,999) (152,325) (154,564) (41,618) (49,398) - (252) (6,276) (14,866) - (1,533)

Surplus/ (Loss) before income tax for the year Income tax expense Net profit / (loss) for the year Other comprehensive income Total other comprehensive income for the year Total comprehensive income for the year Total comprehensive income attributable to the members of the entity 3 (79,670) 14,532

(79,670) 14,532

(79,670) 14,532

(79,670) 14,532

To read the full Financial Report, visit www.anzsnm.org.au Under the members section including the Annual General Meeting proceedings.

2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting

STATEMENT OF FINANCIAL POSITION AS AT 31ST DECEMBER, 2020 Australian and New Zealand Society of Nuclear Medicine Limited ABN 35 133 630 029

STATEMENT OF FINANCIAL POSITION AS AT 31ST DECEMBER, 2020 Note 2020 2019 $ $

ASSETS

CURRENT ASSETS Cash and cash equivalents Trade and other receivables Other assets 4(a) 702,229 737,461 5 26,924 3,128 6 52,469 80,510

TOTAL CURRENT ASSETS

NON-CURRENT ASSETS Property, plant and equipment TOTAL NON-CURRENT ASSETS 781,622 821,099

7 - -

TOTAL ASSETS

781,622 821,099

LIABILITIES

CURRENT LIABILITIES Trade and other payables Revenue in advance

TOTAL CURRENT LIABILITIES

TOTAL LIABILITIES

NET ASSETS

8 91,064 85,817 2(b) 131,591 96,645 222,655 182,462 222,655 182,462 558,967 638,637

EQUITY

Retained earnings

TOTAL EQUITY

558,967 638,637 558,967 638,637

To read the full Financial Report, visit www.anzsnm.org.au Under the members section including the Annual General Meeting proceedings.

2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting

Australian and New Zealand Society of Nuclear Medicine Limited ABN 35 133 630 029

STATEMENT OF CHANGES IN EQUITY STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31ST DECEMBER, 2020

FOR THE YEAR ENDED 31ST DECEMBER, 2020

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31ST DECEMBER 2020

Balance at 1 January, 2019

Profit attributable to the entity

Balance at 31st December, 2019

Profit attributable to the entity

Balance at 31st December, 2020 Retained Earnings Total

$ $ 624,105 624,105 14,532 14,532 638,637 638,637 (79,670) (79,670) 558,967 558,967

Australian and New Zealand Society of Nuclear Medicine Limited ABN 35 133 630 029

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31ST DECEMBER 2020

CASH FLOW FROM OPERATING ACTIVITIES

Receipts from members & other operating activities Interest received Receipts on behalf of ARTnet Payments to suppliers and contractors Net cash provided by operating activities

CASH FLOW FROM INVESTING ACTIVITIES

Payment for property, plant and equipment Payment for intangible asset Net cash used in investing activities Net Increase in cash held Cash at the beginning of the financial year Cash at the end of the financial year

Note 2020 2019 $ $

193,646 369,324 3,074 3,799 - 50,000 (231,952) (338,308) 4(b) (35,232) 84,815

(35,232) 84,815 737,461 652,646 4(a) 702,229 737,461

To read the full Financial Report, visit www.anzsnm.org.au Under the members section including the Annual General Meeting proceedings.

This article is from: